Treatment · June 25, 2026
New Drug to Repair Myelin Wins FDA Approval for Multiple Sclerosis Trials
FDA clears an investigational remyelinating agent for multiple sclerosis treatment....
Breakthrough · June 22, 2026
FDA Clears First Clinical Trial for New Multiple Sclerosis Remyelination Drug
Pheno Therapeutics' MS candidate receives FDA clearance to advance toward clinical trials, offering hope for multiple sclerosis pa...
Breakthrough · March 30, 2026
FDA Approves First Disease Modifying Therapy for Progressive Multiple Sclerosis
FDA made impactful decisions in neurology that advance patient treatment options....